English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Aim: To study clinical features of Cerebral venous sinus thrombosis patients and to assess type of oral anticoagulant, efficacy and Clinical outcome at the end of 3 months. Materials and Methods: Our study was a retrospective observational study. Patients presenting with clinical and imaging features of cerebral venous sinus thrombosis to Fr Muller Medical College hospital from January 2017 till March 2019 were included in the study. Clinical features and outcome was recorded at discharge and at follow up of 3 months. Type of oral anticoagulant used, any complications of therapy, any recurrence of thrombotic events during follow up were recorded. Results: Total of 18 patients were studied. Common Presenting features were headache (83.3%), seizures (38.9%), motor weakness (33.3%) and visual disturbances (27.8%). All patients received therapeutic . Nine (50%) patients received , 5(27.8%) received and 4(22.2%) received during follow up. There were no complications during follow up period. Conclusions: Vitamin K antagonists and Direct oral anticoagulants are equally effective in preventing recurrence of CVST in the short term.  Keywords: Cerebral Venous thrombosis, Anticoagulation, Venous stroke.

Oral anticoagulation in cerebral venous sinus thrombosis-Experience from a tertiary care hospital in Karnataka, South India